← FDA DRUG APPROVALS

FDA ANDA · ANDA076736

FLUCONAZOLE

Sponsor: HIKMA FARMACEUTICA

APPLICATION
ANDA076736
TYPE
ANDA
ORIGINAL APPROVAL
2005-08-23
LATEST ACTION
2025-04-25
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

FLUCONAZOLE IN SODIUM CHLORIDE 0.9%Prescription
FLUCONAZOLE 200MG/100ML (2MG/ML) · INJECTABLE · INJECTION

Approval history

2025-04-25Labeling · Supplement 18 · standardAP
2025-04-25Labeling · Supplement 16 · standardAP
2025-04-25Labeling · Supplement 15 · standardAP
2015-03-19Labeling · Supplement 13 · standardAP
2012-01-25Labeling · Supplement 9AP
2010-11-30Labeling · Supplement 8AP
2008-08-29Labeling · Supplement 6AP
2005-08-23OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →